Insider Cluster (3 insiders) ·Filed Jun 3, 2026

MAZE

Maze Therapeutics, Inc.
BEARISH
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 3 insiders, $1.2M total
Actionable Insight ▼ Bearish

While the absolute dollar amount is routine for a $1.3B market cap, the unanimous selling by the top three insiders (CEO, CSBO, President/CMO) without a single open-market buy creates a bearish optical signal. The CROSS-FILING ACTUARIAL AMPLIFIER applies (cluster-insider-trades + multiple context categories), suggesting these trades may be signaling ahead of earnings or a corporate event. Monitor for any 8-K (2.02 earnings miss or 2.05 restructuring) in the next 14 days — a negative event would validate the cluster's timing and could trigger a 5-7% downside move given the stock's poor T+20 historical calibration.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
MAZE ▲ +8.03% at T+60d
SHORT call ✗ call lost -8.03% · α vs SPY -6.15% · entry $25.40 → $27.44
Entry anchored
Jun 3, 2026
via day open
T+1d
-4.45%
call +4.45% · α +1.85%
$24.27
settled 4mo ago
T+5d
-5.16%
call +5.16% · α +2.60%
$24.09
settled 4mo ago
T+20d
+23.07%
call -23.07% · α -24.44%
$31.26
settled 3mo ago
T+60d
+8.03%
call -8.03% · α -6.15%
$27.44
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Three Maze Therapeutics insiders sold a combined $1.20M in open-market stock over a 6-day window, including the CEO, President/R&D/CMO, and CSBO. None of these sales are 10b5-1 plan trades — all are fully discretionary. The CEO sold the largest tranche ($666K) right before a 2% stock dip, and the President sold after an additional 1.8% decline. At a $1.3B market cap, the cluster represents 0.09% of shares outstanding, falling below the 0.1% materiality threshold, but the complete lack of any insider buying and the uniform selling by the three most senior R&D/C-suite executives warrants heightened scrutiny ahead of the next catalyst event.

Key Financial Metrics

Direction
selling
Total Value
$1.2M
Insiders
3

Key Facts

  • CEO Jason Coloma sold 25,600 shares at $26.02 on May 26 for $666K
  • CSBO Atul Dandekar sold 7,500 shares at $26.34 on May 29 for $198K
  • President/CMO Harold Bernstein sold 13,253 shares at $25.57 on June 1 for $339K
  • Bernstein and Dandekar each exercised stock options at $10.42 to facilitate their sales
  • Total insider selling in the cluster: $1.20M, representing ~0.09% of market cap
  • No open-market insider purchases by any executive in the trailing 30-day period
  • 5 total insider sells in the past 30 days totaling $1.4M (includes this cluster)
  • Historical model performance on MAZE shows 0% win rate at T+20 with -16.73% average return on settled calls

Financial Impact

Insider selling of $1.2M, or ~0.09% of $1.3B market cap — below the 0.1% materiality threshold

insider_salescash_proceeds_to_insiders

Risk Factors

  • Uniform insider selling without any buys increases the risk of adverse news flow near-term
  • Historical MAZE calls underperformed SPY by -19.6% at T+20, indicating persistent selling pressure or disappointing catalysts
  • Cross-filing calibrations flag amplifiers but the score-4/5 neutral calls in the past have still produced -9% T+5 moves
  • If the CEO's sale was pre-planned (10b5-1 is not disclosed in this data), that would reduce the bearish signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MAZE-1780520527450
19 reports for MAZE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MAZE — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 2/10
$26.37 $24.23▼ −8.12%▼ −7.00%$26.69 (+1.20%)
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 3/10
$26.37 $24.23▼ −8.12%▼ −7.00%$26.69 (+1.20%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%$26.69 (+3.16%)
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%$26.69 (+3.16%)
Sep 1, 2026
4w ago
144
NEUTRAL ★ 3/10
$26.72 $24.82▼ −7.11%▼ −6.15%$26.69 (−0.12%)
Aug 17, 2026
6w ago
3
NEUTRAL ★ 1/10
$29.13 $30.42▲ +4.43%▲ +4.63%$26.69 (−8.38%)
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$27.53 $29.75▲ +8.06%▲ +8.51%$26.69 (−3.06%)
Aug 7, 2026
8w ago
Institutional Cluster
BULLISH ★ 5/10
$28.65 $27.18▼ −5.13%▼ −5.53%$26.69 (−6.85%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.81 $27.53▼ −1.01%▼ −1.36%$26.69 (−4.04%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.26 $32.42▲ +3.71%▲ +2.78%$26.69 (−14.63%)
Showing 10 of 19

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 3, 2026